Lemesil

Nimesulide, the active ingredient in Lemesil, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, fever and inflammatory conditions in adults.

GNH USA supplies Lemesil as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lemesil (nimesulide) is employed in the management of several painful and inflammatory conditions that involve cyclooxygenase‑2 mediated pathways. - Pain: provides analgesic relief in acute and chronic musculoskeletal pain. - Fever: reduces elevated body temperature associated with infectious or inflammatory processes. - Osteoarthritis: alleviates joint pain and improves functional mobility. - Dysmenorrhea: eases menstrual cramps and associated discomfort.

Adverse reactions may occur with any NSAID and should be monitored.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient tension‑type headache. - Dizziness: occasional light‑headedness. - Skin rash: mild erythema or pruritus. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, potentially leading to jaundice. - Severe gastrointestinal bleeding or ulceration. - Renal impairment: acute kidney injury, especially in volume‑depleted patients. - Hypersensitivity reactions: anaphylaxis or Stevens‑Johnson syndrome. - Cardiovascular events: increased risk of thrombotic events in susceptible individuals.

Before prescribing Lemesil, clinicians should consider patient‑specific risk factors and monitor appropriately. - Hypersensitivity: avoid in patients with known allergy to nimesulide or other NSAIDs. - Hepatic function: use caution and monitor liver enzymes in patients with liver disease. - Renal function: assess kidney status and adjust use in renal impairment. - Elderly patients: limit duration due to higher risk of gastrointestinal complications. - Concomitant medications: review for potential drug‑drug interactions. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nimesulide may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other NSAIDs or COX‑2 inhibitors: increased risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin, DOACs): heightened bleeding tendency. - Hepatotoxic agents (e.g., isoniazid, methotrexate): potential additive liver injury.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, diuretics): possible reduction in blood‑pressure control. - Lithium: nimesulide may raise serum lithium concentrations. - Corticosteroids: combined use can amplify ulcerogenic risk.